Article

Genetic Markers and Mutations in Primary Spinal Cord Tumors and Their Impact on Clinical Management

2025-08-19

Abstract excerpt

<h4>Background: </h4> Primary spinal cord tumors are rare neoplasms representing 2–4% of central nervous system tumors. Despite their low incidence, their impact on neurological function is profound. Historically, tumor classification and management have relied primarily on histopathology. However, advances in molecular diagnostics have highlighted the critical role of genetic alterations in tumor behavior, progno...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 01d3b83e-d914-585d-9b1b-b2aa9cf6f49a
DOI: 10.20944/preprints202508.1363.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic Markers and Mutations in Primary Spinal Cord Tumors and Their Impact on Clinical ManagementDOI 10.20944/preprints202508.1363.v1Read

Recent Molecular and Genetic Findings in Intramedullary Spinal Cord TumorsSemantic proximity Read

Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomasSemantic proximity Read

Spinal cord tumours: advances in genetics and their implications for treatment.Semantic proximity Read

Molecular Testing of Brain TumorSemantic proximity Read

Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.Semantic proximity Read

Genomic Landscape of Intramedullary Spinal Cord GliomasSemantic proximity Read

Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System.Semantic proximity Read

A review of recently described genetic alterations in central nervous system tumors.Semantic proximity Read

The genomic and transcriptional landscape of the spinal cord H3K27-altered diffuse midline glioma suggests the potential therapeutic strategySemantic proximity Read

Incorporating Advances in Molecular Pathology Into Brain Tumor DiagnosticsSemantic proximity Read

Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.Semantic proximity Read

Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play.Semantic proximity Read